SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 961.85 |
| Enterprise Value ($M) | 601.30 |
| Book Value ($M) | -623.84 |
| Book Value / Share | -3.88 |
| Price / Book | -1.54 |
| NCAV ($M) | -1,055.32 |
| NCAV / Share | -6.56 |
| Price / NCAV | -0.91 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.14 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.97 |
| Current Ratio | 0.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,128.94 |
| Assets | 1,560.42 |
| Liabilities | 2,184.26 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 682.00 |
| Operating Income | -249.00 |
| Net Income | -187.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -87.26 |
| Cash from Investing | -204.04 |
| Cash from Financing | 260.58 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 8.40 | 59.44 | |
| 13G/A | Vanguard Group Inc | 9.63 | 0.00 | |
| 13G/A | State Street Corp | 4.32 | -63.84 | |
| 13G/A | SK Bioscience Co., Ltd. | 4.60 | 0.00 | |
| 13D/A | Shah Capital Management | 7.90 | 2.46 | |
| 13G/A | Morgan Stanley | 1.80 | -66.42 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| . UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,676,369 | 5,704,822 | 29.39 | |
| 2,199,811 | 9,799,483 | 22.45 | |
| 1,463,201 | 4,910,446 | 29.80 | |
| 842,173 | 3,895,274 | 21.62 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NKTX – Nkarta, Inc. | NMRA – Neumora Therapeutics, Inc. |
| NUVL – Nuvalent, Inc. | NXTC – NextCure, Inc. |
| OGI – Organigram Global Inc. |